Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
Q2 2022 vs. Q1 2022
How the institutions holding Cidara Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 44 | 46 | +2 |
| Shares | 30.3M | 27.2M | −3.10M (−10.2%) |
| Value | $25.2M | $13.3M | −$11.9M (−47.3%) |
New holders (8)
Institutions that held Cidara Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| US Bancorp | 262,072 | $128.0K | 0.00% |
| Citadel Advisors LLC | 57,350 | $28.0K | 0.00% |
| Jane Street Group, LLC | 40,625 | $20.0K | 0.00% |
| Virtu Financial LLC | 25,886 | $13.0K | 0.00% |
| Fisher Asset Management, LLC | 18,800 | $9.00K | 0.00% |
| Ground Swell Capital, LLC | 11,397 | $6.00K | 0.01% |
| HRT Financial LP | 10,208 | $4.00K | 0.00% |
| Group One Trading, L.P. | 405 | $0 | 0.00% |
Sold out (6)
Institutions that held Cidara Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Monashee Investment Management LLC | 369,099 | $307.0K |
| Two Sigma Investments, LP | 20,532 | $17.0K |
| Occudo Quantitative Strategies LP | 14,522 | $12.0K |
| Schonfeld Strategic Advisors LLC | 10,900 | $9.00K |
| Bollard Group LLC | 7,733 | $6.00K |
| Simplex Trading, LLC | 636 | $0 |